Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-131704
Filing Date
2024-12-26
Accepted
2024-12-26 16:01:17
Documents
1
Period of Report
2024-12-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2432058-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2432058-1_4seq1.xml 4 5472
  Complete submission text file 0001104659-24-131704.txt   7225
Mailing Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 888 SEVENTH AVE 29TH FL NEW YORK NY 10106
Business Address
ELMS STEVE (Reporting) CIK: 0001250195 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37939 | Film No.: 241581001